-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Initiates Coverage On LB Pharmaceuticals with Buy Rating, Announces Price Target of $68

Benzinga·10/02/2026 09:21:01
Needham analyst Ami Fadia initiates coverage on LB Pharmaceuticals (NASDAQ:LBRX) with a Buy rating and announces Price Target of $68.